Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Æä±×ÀÎÆ®·ÐÁÖ»ç50mcg - »õâ
|
½¦¸µÇª¶ó¿ìÄÚ¸®¾Æ |
E04060431 | PegInterferon Alpha-2b | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Æä±×ÀÎÆ®·ÐÁÖ»ç80mcg - »õâ
|
½¦¸µÇª¶ó¿ìÄÚ¸®¾Æ |
E04060421 | PegInterferon Alpha-2b | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Æä±×ÀÎÆ®·ÐÁÖ»ç100mcg - »õâ
|
½¦¸µÇª¶ó¿ìÄÚ¸®¾Æ |
E04060411 | PegInterferon Alpha-2b | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Æä±×ÀÎÆ®·ÐÁÖ»ç120mcg - »õâ
|
½¦¸µÇª¶ó¿ìÄÚ¸®¾Æ |
E04060401 | PegInterferon Alpha-2b | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Æä±×ÀÎÆ®·ÐÁÖ»ç150mcg - »õâ
|
½¦¸µÇª¶ó¿ìÄÚ¸®¾Æ |
E04060391 | PegInterferon Alpha-2b | Àü¹®ÀǾàǰ | ±Þ¿© |
| PEG-Intron |
A drug used to treat hepatitis C infections. It is also being studied in the treatment and prevention of cancer. It is a cytokine that is modified in the laboratory. It belongs to the family of drugs called biological response modifiers. Also called PEG-interferon alfa-2b and SCH 54031.
Ãâó: www.stjude.org/glossary
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|